As of 2025-07-06, the Intrinsic Value of Bioxytran Inc (BIXT) is -0.16 USD. This BIXT valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 USD, the upside of Bioxytran Inc is -263.19%.
Based on its market price of 0.10 USD and our intrinsic valuation, Bioxytran Inc (BIXT) is overvalued by 263.19%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.16 - -0.16 | -0.16 | -263.19% |
| P/E | (0.02) - (0.03) | (0.03) | -129.4% |
| DDM - Stable | (0.41) - (7.67) | (4.04) | -4140.1% |
| DDM - Multi | (0.56) - (8.26) | (1.06) | -1155.5% |
| Market Cap (mil) | 8.89 |
| Beta | -1.66 |
| Outstanding shares (mil) | 88.88 |
| Enterprise Value (mil) | 9.65 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.97% |
| Cost of Debt | 5.00% |
| WACC | 6.39% |